Associate Director, Oncology Marketing - Core Brand

Sleepy Hollow, NY (On-site)

$157K/yr – $257K/yrManager5+ years expFull time

Posted 3 months ago

Job Summary

Original Job Description

Regeneron logo

Regeneron

Glassdoor
3.9

At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in. Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media.

Marketing team
772
Employees
16K
Headquarters
Tarrytown, New York, USA
Founded
1988

Employee Sentiment

Overall Rating
3.9 / 5
Recommend to a Friend
73%
CEO Approval
88%
Source: Glassdoor

Traffic Signals

Monthly Visitors
355.2K
Monthly Google Ads Budget
$56.8K
Traffic Source Mix
Search
40.8%
Direct
42.2%
Referral
9.5%
Social
6.3%
Paid
1%

Headcount Trend

Current headcount: ~16.5K

Marketing Team

Marketing Team Size
688 (4% of company)
Marketing Roles Posted (Last 30 Days)
1

Funding

Total Funding
$15.9M
Last Raise
2 years ago
Last Raise Amount
$2.0M
  • 2024-07-11
    Post IPO Equity • $2.0M
  • 2023-10-18
    Post IPO Equity • $5.0M
  • 2016-08-22
    Post IPO Equity • $8.9M

Recent News

Reuters
Regeneron's experimental therapy combo effective in untreated cancer patients
Dec 6, 2025
BioPharma Dive
Regeneron inks gene editing deal with startup Tessera
Dec 1, 2025
Fierce Biotech
Regeneron makes $150M bet on Tessera's rare disease gene writing prospect
Dec 1, 2025